These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66 related articles for article (PubMed ID: 10895080)
1. On the cardiac contractile, electrophysiological and biochemical effects of endothall, a protein phosphatase inhibitor. Bokník P; Vahlensieck U; Huke S; Knapp J; Linck B; Lüss H; Müller FU; Neumann J; Schmitz W Pharmacology; 2000 Jul; 61(1):43-50. PubMed ID: 10895080 [TBL] [Abstract][Full Text] [Related]
2. On the cardiac contractile, biochemical and electrophysiological effects of cantharidin, a phosphatase inhibitor. Neumann J; Herzig S; Boknik P; Apel M; Kaspareit G; Schmitz W; Scholz H; Tepel M; Zimmermann N J Pharmacol Exp Ther; 1995 Jul; 274(1):530-9. PubMed ID: 7616441 [TBL] [Abstract][Full Text] [Related]
3. Contractility and inhibition of protein phosphatases by cantharidin. Knapp J; Bokník P; Huke S; Gombosová I; Linck B; Lüss H; Müller FU; Müller T; Nacke P; Schmitz W; Vahlensieck U; Neumann J Gen Pharmacol; 1998 Nov; 31(5):729-33. PubMed ID: 9809469 [TBL] [Abstract][Full Text] [Related]
4. Biochemical and electrophysiological mechanisms of the positive inotropic effect of calyculin A, a protein phosphatase inhibitor. Neumann J; Bokník P; Herzig S; Schmitz W; Scholz H; Wiechen K; Zimmermann N J Pharmacol Exp Ther; 1994 Oct; 271(1):535-41. PubMed ID: 7965753 [TBL] [Abstract][Full Text] [Related]
5. Mechanisms of the contractile effects of 2,3-butanedione-monoxime in the mammalian heart. Zimmermann N; Boknik P; Gams E; Gsell S; Jones LR; Maas R; Neumann J; Scholz H Naunyn Schmiedebergs Arch Pharmacol; 1996 Oct; 354(4):431-6. PubMed ID: 8897445 [TBL] [Abstract][Full Text] [Related]
6. Evidence for physiological functions of protein phosphatases in the heart: evaluation with okadaic acid. Neumann J; Boknik P; Herzig S; Schmitz W; Scholz H; Gupta RC; Watanabe AM Am J Physiol; 1993 Jul; 265(1 Pt 2):H257-66. PubMed ID: 8393625 [TBL] [Abstract][Full Text] [Related]
7. Protein phosphatase 2A and its [3H]cantharidin/[3H]endothall thioanhydride binding site. Inhibitor specificity of cantharidin and ATP analogues. Li YM; Mackintosh C; Casida JE Biochem Pharmacol; 1993 Oct; 46(8):1435-43. PubMed ID: 8240393 [TBL] [Abstract][Full Text] [Related]
8. Endothall thioanhydride inhibits protein phosphatases-1 and -2A in vivo. Erdödi F; Tóth B; Hirano K; Hirano M; Hartshorne DJ; Gergely P Am J Physiol; 1995 Nov; 269(5 Pt 1):C1176-84. PubMed ID: 7491907 [TBL] [Abstract][Full Text] [Related]
9. Pharmacological characterization of protein phosphatase activities in preparations from failing human hearts. Neumann J; Maas R; Bokník P; Jones LR; Zimmermann N; Scholz H J Pharmacol Exp Ther; 1999 Apr; 289(1):188-93. PubMed ID: 10087003 [TBL] [Abstract][Full Text] [Related]
10. Cantharidin-binding protein: identification as protein phosphatase 2A. Li YM; Casida JE Proc Natl Acad Sci U S A; 1992 Dec; 89(24):11867-70. PubMed ID: 1334551 [TBL] [Abstract][Full Text] [Related]
11. Inhibitory action of the phosphatase inhibitor cantharidin on the endothelin-1-induced and the carbachol-induced negative inotropic effect in the canine ventricular myocardium. Chu L; Norota I; Ishii K; Endoh M J Cardiovasc Pharmacol; 2003 Jan; 41 Suppl 1():S89-92. PubMed ID: 12688404 [TBL] [Abstract][Full Text] [Related]